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Assessment of a Small Molecule Synthetic Lignan in Enhancing Oxidative
Balance and Decreasing Lipid Accumulation in Human Retinal Pigment Epithelia
Abstract
Visual function depends on the intimate structural, functional and metabolic interactions between the
retinal pigment epithelium (RPE) and the neural retina. The daily phagocytosis of the photoreceptor outer
segment tips by the overlaying RPE provides essential nutrients for the RPE itself and photoreceptors
through intricate metabolic synergy. Age-related retinal changes are often characterized by metabolic
dysregulation contributing to increased lipid accumulation and peroxidation as well as the release of
proinflammatory cytokines. LGM2605 is a synthetic lignan secoisolariciresinol diglucoside (SDG) with
free radical scavenging, antioxidant and anti-inflammatory properties demonstrated in diverse in vitro and
in vivo inflammatory disease models. In these studies, we tested the hypothesis that LGM2605 may be an
attractive small-scale therapeutic that protects RPE against inflammation and restores its metabolic
capacity under lipid overload. Using an in vitro model in which loss of the autophagy protein, LC3B, results
in defective phagosome degradation and metabolic dysregulation, we show that lipid overload results in
increased gasdermin cleavage, IL-1 β release, lipid accumulation and decreased oxidative capacity. The
addition of LGM2605 resulted in enhanced mitochondrial capacity, decreased lipid accumulation and
amelioration of IL-1 β release in a model of defective lipid homeostasis. Collectively, these studies
suggest that lipid overload decreases mitochondrial function and increases the inflammatory response,
with LGM2605 acting as a protective agent. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords
Antioxidant; Inflammation; Ketogenesis; LGM2605; Lipid steatosis; Oxidative stress; Retina; Small
molecule therapeutics

Disciplines
Dentistry

Author(s)
Anuradha Dhingra, Rachel C. Sharp, Taewan Kim, Anatoliy V. Popov, Gui-Shuang Ying, Ralph A. Pietrofesa,
Kyewon Park, Melpo Christofidou-Solomidou, and Kathleen Boesze-Battaglia

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/dental_papers/417

International Journal of

Molecular Sciences
Article

Assessment of a Small Molecule Synthetic Lignan in Enhancing
Oxidative Balance and Decreasing Lipid Accumulation in
Human Retinal Pigment Epithelia
Anuradha Dhingra 1 , Rachel C. Sharp 1 , Taewan Kim 2 , Anatoliy V. Popov 3 , Gui-Shuang Ying 4 ,
Ralph A. Pietrofesa 5 , Kyewon Park 4 , Melpo Christofidou-Solomidou 5 and Kathleen Boesze-Battaglia 1, *
1

2

3

4

5



Citation: Dhingra, A.; Sharp, R.C.;
Kim, T.; Popov, A.V.; Ying, G.-S.;
Pietrofesa, R.A.; Park, K.;
Christofidou-Solomidou, M.;
Boesze-Battaglia, K. Assessment of a
Small Molecule Synthetic Lignan in
Enhancing Oxidative Balance and
Decreasing Lipid Accumulation in
Human Retinal Pigment Epithelia.
Int. J. Mol. Sci. 2021, 22, 5764.
https://doi.org/10.3390/ijms22115764
Academic Editor: Janusz Blasiak
Received: 6 May 2021
Accepted: 26 May 2021
Published: 28 May 2021

*

Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania,
Philadelphia, PA 19104, USA; dhingra@upenn.edu (A.D.); rachelcsharp3@gmail.com (R.C.S.)
Department of Periodontics, School of Dental Medicine, University of Pennsylvania,
Philadelphia, PA 19104, USA; taewank@dental.upenn.edu
Department of Radiology, Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA 19104, USA; avpopov@pennmedicine.upenn.edu
Center for Preventive Ophthalmology and Biostatistics, Perelman School of Medicine, University of
Pennsylvania, Philadelphia, PA 19104, USA; gsying@pennmedicine.upenn.edu (G.-S.Y.);
kyewpark@pennmedicine.upenn.edu (K.P.)
Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;
ralphpietrofesa@gmail.com (R.A.P.); melpo@pennmedicine.upenn.edu (M.C.-S.)
Correspondence: battagli@upenn.edu

Abstract: Visual function depends on the intimate structural, functional and metabolic interactions
between the retinal pigment epithelium (RPE) and the neural retina. The daily phagocytosis of
the photoreceptor outer segment tips by the overlaying RPE provides essential nutrients for the
RPE itself and photoreceptors through intricate metabolic synergy. Age-related retinal changes are
often characterized by metabolic dysregulation contributing to increased lipid accumulation and
peroxidation as well as the release of proinflammatory cytokines. LGM2605 is a synthetic lignan secoisolariciresinol diglucoside (SDG) with free radical scavenging, antioxidant and anti-inflammatory
properties demonstrated in diverse in vitro and in vivo inflammatory disease models. In these studies, we tested the hypothesis that LGM2605 may be an attractive small-scale therapeutic that protects
RPE against inflammation and restores its metabolic capacity under lipid overload. Using an in vitro
model in which loss of the autophagy protein, LC3B, results in defective phagosome degradation and
metabolic dysregulation, we show that lipid overload results in increased gasdermin cleavage, IL-1 β
release, lipid accumulation and decreased oxidative capacity. The addition of LGM2605 resulted in
enhanced mitochondrial capacity, decreased lipid accumulation and amelioration of IL-1 β release
in a model of defective lipid homeostasis. Collectively, these studies suggest that lipid overload
decreases mitochondrial function and increases the inflammatory response, with LGM2605 acting as
a protective agent.
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1. Introduction
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Attribution (CC BY) license (https://
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Visual function depends on the intimate structural, functional and metabolic interactions between the retinal pigment epithelium (RPE) and the neural retina (NR). In the aging
human eye, oxidative damage, metabolic dysregulation and accumulation of pro-oxidant
compounds cause the functional decline of the RPE, which contributes to age-related macular degeneration (AMD) [1–3]. AMD is a late-onset, progressive disease that generally
affects individuals over the age of 60 [4]. It is the major cause of vision loss in the elderly,
affecting over 2 million people in the US. With the aging of “baby-boomers”, the number
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of AMD cases is predicted to double by the year 2050 [4]. Uncompensated oxidative stress
is a major contributor to RPE dysfunction and cell injury, and in AMD is a known risk
factor in disease progression. AMD donor eyes have higher levels of oxidatively modified
proteins, DNA and lipids [5]. In animal models of chronic oxidative stress, the retina and
RPE develop pathologic lesions characteristic of early AMD [6,7]. RPE are at high risk
for oxidative stress as they constantly manage reactive oxygen species resulting from an
oxygen-rich environment, high metabolic activity and high flux of polyunsaturated fatty
acids as well as exposure to the oxidizing effects of blue light [8,9]. Undegraded lipids
serve as substrates for peroxidation reactions in this oxidative environment [9,10].
Over time, RPE, the single layer of epithelia, suffers from cumulative oxidative stress
due to a combination of normal physiological as well as environmental factors. In this
context, it is essential to understand the multifunctional role played by the RPE in retinal
homeostasis. RPE function includes light absorption, heat exchange, Vitamin A metabolism,
outer blood retinal barrier nutrient exchange and maintenance of chorio-capillaries [11].
Perhaps one of the most critical functions in maintaining photoreceptor physiological
function is the daily renewal of photoreceptor constituents. Photoreceptor rods and cones
as well as the overlying RPE are terminally differentiated, thus, to maintain structure and
function, the photoreceptors rely on the diurnal phagocytosis and digestion of photoreceptor outer segment tips (OS) by the RPE. In the human retina, we estimate that each RPE
ingests ~0.08–0.15 pmoles of fatty acid for fatty acid oxidation [12]. The daily phagocytosis
and subsequent degradation of the lipid-rich OSs provide energy to the RPE through
mitochondrial fatty acid oxidation and generate ketones bodies for use by the photoreceptors [13,14]. Because of this critical and continuous dependence of photoreceptors on
RPE, any functional deficiency in RPE ultimately harms photoreceptors and impairs vision.
Defects in phagocytic function and fatty acid oxidative capacity phenocopies aspects of
aging and age-related retinal disease. These conditions are characterized by degeneration of
the RPE, which includes the formation of atrophic patches of RPE and subretinal migration
of activated microglial cells as well as sub-RPE deposition of inflammatory and oxidatively
damaged proteins [3,11,15–18].
Virtually all cell types in the eye rely on one or more aspects of autophagy to maintain structure and/or normal physiological function [11,19]. Autophagy is also a critical
regulator of RPE homeostasis, playing an important role in protection against oxidative
stress [20–22]. Mutations in or loss of specific autophagy components are associated
with the accumulation of proteins and damaged organelles, a common characteristic of
the aging RPE as well as of AMD [23–26]. The RPE utilizes autophagy proteins, specifically LC3B, in the degradation of ingested photoreceptor outer segments, similar to the
phagocytic function in macrophages and dendritic cells [27–31]. The daily burst of OS
phagocytosis is accompanied by an increase in LC3, levels of which fluctuate over the 12
h light/dark cycle [32,33]. The RPE relies on LC3 to maintain functional mitochondria
and peroxisomes [20,34] and as a critical component of a phagocytosis degradative pathway termed LC3-associated phagocytosis (LAP) [16,29–32]. The RPE has adapted LAP
to eliminate stressors, including the daily ingestion of lipids and proteins in the form of
OS tips [14,16,32]. LC3B-associated processes play a critical role in visual pigment regeneration and phagosome degradation [16,28,32], with loss of LAP resulting in decreased
retinal function [16] and dysregulated lipid metabolism [14]. Our own previous studies
established that loss of the autophagy protein LC3B leads to lipid accumulation, peroxidation, ketogenic insufficiency and induction of a proinflammatory microenvironment [27].
Collectively, such dysregulation contributed to the loss of both retinal and RPE function as
assessed by ERG [27].
A unique synthetic lignan secoisolariciresinol diglucoside (SDG), LGM2605, a small
molecule therapeutic, also restores mitochondrial homeostasis [35]. SDG has potent free
radical scavenging and antioxidant properties and confirms its DNA radioprotective
properties in cell-free systems [36] as well as in cells [37,38]. In preclinical models in
mice [35,39–41], non-human primates [42] and in an ex vivo lung organ culture model
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of proton-irradiated human lung, LGM2605 [43] has been shown to be highly efficacious.
LGM2605 exhibits free radical scavenging, antioxidant and anti-inflammatory properties in
diverse inflammatory cells (Rom, 2018 #43; Kokkinaki, 2019 #38; Christofidou-Solomidou,
2012 #55; Mishra, 2013 #48; Velalopoulou, 2017 #47; Velalopoulou, 2015 #42; Pietrofesa, 2016
#62; Pietrofesa, 2017 #54). Most recently, LGM2605 has been shown to improve metabolic
function in cardiomyocytes [35].
In these studies, we tested the hypothesis that LGM2605 may be an attractive smallscale therapeutic that restores metabolic capacity to RPE under lipid overload and protects
against inflammation. Using an in vitro model of defective phagosome degradation and
metabolic dysregulation, we show that lipid overload results in increased gasdermin
cleavage, IL-1 β release, lipid accumulation and decreased oxidative capacity. The addition
of LGM2605 resulted in enhanced mitochondrial capacity, decreased lipid accumulation
and amelioration of IL-1 β release. Collectively, these studies suggest that lipid overload
increases the inflammatory response and mitochondrial overload, with LGM2605 acting as
a protective agent.
2. Materials and Methods
2.1. Materials
The following antibodies were used for immunoblotting (dilution; company information): mouse anti-β-actin (1:5000; A2228; Sigma-Aldrich, St. Louis, MI, USA), mouse antiopsin mAb 4D2 (1:1000; a generous gift from Dr. R. Molday, University of British Columbia,
Vancouver, BC, Canada), rabbit anti-gasdermin (GSDRM) (1:1000, NBP2-33422; Novus,
Littleton, CO, USA), goat anti-mouse and goat anti-rabbit HRP-conjugated secondary
antibody (1:3000; 32430 and 31462; Invitrogen, Carlsbad, CA, USA). Bovine photoreceptor
outer segments (OS) were from Invision Bioresources (Seattle, WA, USA).
We independently generated synthetic SDG (referred to as LGM2605 in the literature), as previously described [44]. Briefly, secoisolariciresinol diglucosides (S,S)-SDG
(the major isomer in whole grain flaxseed) and (R,R)-SDG (the minor isomer in whole
grain flaxseed) were synthesized from vanillin via secoisolariciresinol and glucosyl donor
(perbenzoyl-protected trichloacetimidate under the influence of TMSOTf) through a concise route involving chromatographic separation of diastereomeric diglucoside derivatives
(Chemveda Life Sciences Inc., Hyderabad, India). Absorbance spectra of 36mM LGM2605
measured using a SpectraMax M5 fluorescent plate reader (Molecular Devices, San Jose,
CA, USA).
2.2. Generation of RPE-LC3B
Prepackaged lentiviral particles that either encoded a nontargeting shRNA (negative
shRNA; sc-108080) or sequences specifically targeting the human gene MAP1LC3B (sc43390-V) were purchased from a commercial provider (Santa Cruz Biotechnology, Dallas,
TX, USA). LC3B knockdown cells were generated by transducing ARPE-19 with MAP1LC3B
shRNA lentiviral particles, sc-43390-V. ARPE-19 cells were passaged and subsequently
(within 24 h) transduced with the shRNA lentiviral particles with a multiplicity of infection
(MOI) of five in the presence of 8 µg/mL hexadimethrine bromide and incubated at 37
◦ C for 18–20 h [45]. Fresh media was added and cells were incubated overnight. Media
were then replaced with media containing 2 µg/mL puromycin for selection purposes
and changed every 3–4 days until resistant colonies could be identified. The control
cell lines were generated by transducing ARPE-19 cells with negative shRNA, sc-108080.
Knockdown of the MAP1LC3B gene was confirmed by real-time polymerase chain reaction
and of LC3B protein by Western blot analysis.
2.3. Maintenance of RPE Cell Culture
ARPE-19 cells—(CRL-2302, ATCC) were maintained as we have described [46]. Polarized ARPE (or RPE), RPE-MREG and RPE-LC3B were cultured as described [14,45]. In brief,
cells were grown on Transwell filters (12-well, 0.4-µm pore size) maintained in DMEM/F12

Int. J. Mol. Sci. 2021, 22, 5764

4 of 20

with 1% fetal bovine serum (Sigma, St. Louis, MI, USA) and 5% penicillin-streptomycin
(Life Technologies Inc., Carlsbad, CA, USA) or on glass-bottom dishes at 37 ◦ C, 5% CO2 .
Individual filters were seeded with 1.6 × 105 cells/well in a total volume of 0.5 mL in the
apical chamber and 1.5 mL of medium in the basal chamber, with the medium changed
twice weekly beginning the day after plating.
2.4. Cell Stress Studies
RPE and RPE-LC3B cells were treated with H2 O2 (200 µM or 600 µM) and 10 ng/mL
TNF-α to induce oxidative stress, as described previously [47,48]. Briefly, cells were plated
on 12 well plates 48 h prior to the start of the experiment. On day 2, cells were treated
with H2 O2 and 10ng/mL TNF-α for 6 min. Stressed cells were washed and subsequently
fed OS, at a ratio of 10:1 (10 particles/cell). Supernatants and cell lysates were collected
10 h and 24 h after treatment. In some studies, the cells were pretreated with LGM2605
(50–200 µM) in serum-free media for 30 min prior to H2 O2 + TNF-α stress induction.
2.5. OS Phagocytic Challenge and LGM2605 Treatment
2.5.1. Challenge with Photoreceptor Outer Segments (OS)
RPE and RPE-LC3B cells were challenged with OS using either a single pulse/chase
challenge or multiple pulse/chase challenges over a 5–7 day period. Pulse/chase studies
were begun with the removal of the existing media and cells were rinsed three times
with growth media. OS at a ratio of 10:1 (10 particles/cell) were added to the apical
chamber in fresh growth media and incubated at 37 ◦ C for 2 h (pulse). After 2 h pulse,
cells were rinsed three times with growth media, fresh growth media was added, and
phagosome degradation was allowed to continue for up to 24 h (chase) [14,32]. The
assay was terminated at designated time points with the removal of apical supernatant
media, cells washed three times (37 ◦ C PBS-CM), and filters immediately processed for
immunofluorescence microscopy or lysates prepared for western blot analysis or gene
expression studies. These samples were collected at the times indicated in the Figure
Legends.
In our long-term OS challenge studies, a pulse/chase series was repeated daily for
5–7 days, essentially as described in [49]. In those studies, on experimental day 0, the
culture medium was removed from 3–5 wells and replaced either with medium or with
OS at a ratio of 10:1 (10 particles/cell) in fresh growth media and incubated at 37 ◦ C
for 2 h (pulse). Cells were washed thoroughly with an isotonic solution to remove non
internalized OSs, followed by a 2 h chase in media. In experiments using LGM2605, cells
were incubated with LGM2605 (100 µM in serum-free media) for 30 min daily and rinsed
with PBS prior to the addition of OSs. At the end of the long-term OS challenge, as indicated in the individual Figure legends, cells were analyzed for neutral lipid accumulation
(BODIPY™493/503), lipid peroxidation adducts (4-HNE), IL-1 β secretion, cell integrity,
(transepithelial resistance, TER) and actin staining, as well as mitochondrial function (βHB).
All assays are described in detail below.
2.5.2. Treatment with LGM2605
Cells were pretreated with increasing concentrations of LGM2605 (50–200 µM) in
serum-free media for 30 min prior to either H2 O2 + TNF-α stress induction or the addition
of OS. In brief, lyophilized LMG2605 was freshly resuspended before each experiment,
according to packaging instructions.
2.6. RNA Isolation and Gene Expression Analysis
Total RNA was isolated using a RNeasy Plus Mini Kit and quantitative polymerase
chain reaction (qPCR) analysis was performed, as previously described [38,43,50,51]. Total
RNA was quantified using a NanoDrop 2000 apparatus (Thermo Fisher Scientific, Waltham,
MA, USA). Reverse transcription of RNA to cDNA was then performed on a Veriti® Thermal Cycler using the High Capacity RNA-to-cDNA Kit (Applied Biosystems, Thermo Fisher
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Scientific, Waltham, MA, USA). qPCR was performed using individual TaqMan® ProbeBased Gene Expression Assays (Applied Biosystems, Thermo Fisher Scientific, Waltham,
MA, USA). Individual TaqMan gene expression assays were selected for nuclear factor
(erythroid-derived 2)-like 2 (Nrf2) regulated genes, NADPH: quinone oxidoreductase-1
(NQO1), glutathione S-transferase mu 1 (GSTM1), and heme oxygenase-1 (HO-1). qPCR
was performed using 50 ng of cDNA per reaction well on an Applied Biosystems QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems, Thermo Fisher Scientific, Waltham,
MA, USA). Gene expression data are presented normalized to the housekeeping gene
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Gene expression analysis was also
performed using two additional housekeeping genes, 18S ribosomal RNA (18S rRNA) and
β-actin for validation. All data were calibrated to the control, untreated samples (RPE Ctrl)
according to the ∆∆CT method as previously described [52].
2.7. Immunoblotting
Cell lysates were prepared in RIPA buffer with 1% protease inhibitor mixture (Sigma;
P8340, St. Louis, MI, USA) and 2% phosphatase inhibitor mixture 2 (Sigma; P5726, St.
Louis, MI, USA). 10–15 µg of the protein per sample was separated on 4–12% Bis-TrisPAGE (Invitrogen, Carlsbad, CA, USA) under reducing conditions and transferred to PVDF
membranes (Millipore, Billerica, MA, USA). After transfer, membranes were blocked with
5% milk in PBS, 0.1% Tween-20 for 1 h at room temperature and incubated with primary
antibodies for anti-β-actin (1:5000), anti-gasdermin (1:1000), anti-opsin mAb 4D2 (1:1000)
overnight at 4 ◦ C. Membranes were washed and incubated with goat anti-rabbit (1:3000)
or goat anti-mouse (1:3000) horseradish peroxidase-conjugated secondary antibodies for
1 h at room temperature. The blots were developed using ECL (SuperSignal® West Dura
extended duration substrate (Thermo Scientific, Waltham, MA, USA) and captured on
Li-Cor Odyssey Fc image reader and quantified as described [14].
2.8. Staining for Neutral Lipids
BODIPY™493/503 (4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene,
Molecular Probes, Eugene, OR, USA; D3922) was used to visualize neutral lipid-rich
deposits. BODIPY™493/503 stock solution (0.5 mg/mL) was prepared in 100% ethanol
and diluted in 1xPBS to 10 µg/mL before the experiment. Cells (RPE and RPE-LC3B ) were
incubated with OS as described above. Cells were fixed with 4% PFA for 10 min at RT,
washed in PBS, incubated in BODIPYTM 493/503 for 1 h at RT in the dark, followed by
nuclear staining (Hoechst 33298) and three, 5-min PBS washes. Images were captured
on a Nikon A1R laser scanning confocal microscope with a 60X water objective at 18 ◦ C,
and the data were analyzed using Nikon Elements AR 4.30.01 software [27]. Briefly, after
background subtraction, sum intensity for the BODIPY™493/503 staining was obtained
for each image. The intensity measure for each field was normalized relative to the number
of cells in the field and averaged (n = 3).
2.9. Staining for Mitochondria
Mitochondria were visualized using MitoTracker™ Red CMXRos (Invitrogen M7512,
Carlsbad, CA, USA). Cells (RPE and RPE-LC3B ) grown on glass-bottom dishes were pretreated with 100 µM LGM for 30 min as described above. The cells were rinsed in serum-free
media followed by incubation with 400 nM MitoTracker™ Red CMXRos diluted in serumfree medium at 37 ◦ C for 15 min, essentially as described [35,53]. The cells were washed
in serum-free media (3 × 5 min) and fixed in 4% paraformaldehyde for 10 min. After
Hoechst33298 staining and 3 successive PBS washes, the cells were imaged on a Nikon A1R
laser scanning confocal microscope with a 100X oil objective at 18 ◦ C, and the data were
analyzed using Nikon Elements AR 4.30.01 software. Briefly, after background subtraction,
sum intensity was obtained for each image and the intensity measure for each field was
normalized to the number of cells in the field and averaged (n = 3).
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2.10. Staining for Actin
For actin filament staining, cells were fixed in 4% PFA, washed, permeabilized and
blocked in blocking solution containing 5% BSA and 0.2% Triton X-100 in PBS (PBST) at
37 ◦ C for 1 h, incubated with the Alexa Fluor 594 Phalloidin (1 Unit/200 µL) (Invitrogen,
Carlsbad, CA, USA, A12381) o/n at 4 ◦ C, washed in PBST and imaged using a Nikon A1R
laser scanning confocal microscope with a PLAN APO VC 60× water (NA 1.2) objective at
18 ◦ C
2.11. Transepithelial Resistance (TER)
Transepithelial electrical resistance (TER) of RPE and RPE-LC3B grown on 12-well
transwell inserts (12 mm diameter, 0.4 µM pore size, Corning, UK) were measured as an
indicator of barrier integrity/polarisation using an EVOM2 epithelial voltohmmeter and
4 mm STX2 chopstick electrode per the manufacturer’s instructions (World Precision Instruments Inc., Sarasota, FL, USA). After the electrode was sterilized in 70% ethanol, rinsed in
ddH20 and equilibrated in prewarmed culture medium, it was simultaneously introduced
into both chambers. TER measurements from at least three cultures per condition, no
addition (NA), +LGM2605 (100 µM), +OS and +OS and LGM2605 (100 µM) were obtained
over a period of 7 days. Measurements were made every other day. All measurements
were performed within 6 min at room temperature after removal from the incubator.
2.12. TUNEL Staining
For Tunel staining of cells, ApoTag in situ apoptosis kit (Chemicon, Miyagi, Japan)
as we have described previously [54]. Briefly, 4% PFA fixed cells were post-fixed in prechilled ethanol: acetic acid (2:1) for 5 min at −20 ◦ C, washed, treated with proteinase K
(20 ug/mL) for 5 min at RT. The cells were then incubated in equilibration buffer, treated
with terminal deoxynucleotidyl transferase (TdT) enzyme at 37 ◦ C for 1h, incubated with
anti-digoxigenin fluorescein conjugate (1:1) at RT for 30 min, followed by nuclear staining
(Hoechst 33258) and imaging.
2.13. Ketone Body Measurements, β-Hydroxybutyrate (β-HB) Assay
Preparation of metabolic substrates—Ringer’s solution was prepared using the basic
chemical components of RPE cell culture medium: CaCl2 (1.1 mM), KCl (4.2 mM), NaCl
(120.6 mM), NaHCO3 (14.3 mM), MgCl2 (0.3 mM) and HEPES (15 mM). HEPES was
dissolved separately and titrated to pH 7.4 with N-methyl-D-glucamine. L-Carnitine
(1 mM) in Ringer’s solution was added immediately before each experiment; the solution
was equilibrated to pH 7.4 with CO2 and filter-sterilized. Photoreceptor OSs purified from
frozen dark-adapted bovine retinas were added to cultured RPE cells as indicated above.
The phospholipid content of the OS was determined using a Malachite Green assay kit per
the manufacturer’s instructions (K-1500; Echelon Biosciences, Salt Lake City, UT, USA) as
originally described in (46). On the day of the experiment, the OSs were thawed, pelleted
and resuspended in Ringer’s solution at a final concentration of 200 µM (based on total
phospholipid content). Ringer’s solution containing different substrates was added to the
apical chamber of RPE, RPE-MREG and RPE-LC3B cells grown on 12-well Transwell filters.
Ringer’s solution (115 µL) was collected from the apical and basal chamber and analyzed
for β-HB at the 2 and 3 h time points essentially using the β-hydroxybutyrate LiquiColor
kit (Stanbio, Boerne, TX, USA; catalog no. 2440-058) as described previously [14]. No βHB
was detected with OS alone. In studies utilizing LGM2605, the cells were preincubated for
30 min with 100 µM LGM2605.
2.14. Lactate Dehydrogenase (LDH) Assay
LDH released into the extracellular solution was measured as an indicator of cell
membrane integrity using a coupled reaction where tetrazolium salt was reduced to the
colored product formazan by enzyme activity (cytotoxicity detection kit LDH; Roche
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Applied Science, Mannheim, Germany) as we have described previously [54,55]. The
solution itself did not affect the LDH assay.
2.15. Lipid Peroxidation
RPE lysates were isolated, as described above, at the indicated time points and immediately prepared for 4-HNE analysis. Cleared RPE lysates obtained by centrifugation
at 2000× g for 3 min were used in twofold series dilutions. Samples were analyzed using 4-HNE-ELISA kit from Cell Biolabs, San Diego, CA, United States according to the
manufacturer’s directions using a Multiskan MCC plate reader (Thermo Fisher Scientific,
Waltham, MA, United States) [27]. Protein was quantified using Bradford reagent (Thermo
Fisher, Waltham, MA, USA).
2.16. Cytokine Analysis
Cytokine production was measured in the culture supernatants from RPE and RPE-LC3B
cells challenged as described above in the presence or absence of LGM2605 at the concentrations indicated in the Figure legends. Culture supernatants collected at the time points
indicated in the figure legends were analyzed by ELISA for IL-1 β (Quantikine Elisa Kit;
R&D Systems) and IL-18 (Quantikine Elisa kit; R&D Systems, #DL180) commercially available kits according to the manufacturer’s instructions [55]. In each instance, the amount of
cytokine present in the supernatant was determined using a standard curve.
2.17. Statistical Analyses
We used a two-way analysis of variance (ANOVA) to evaluate the effect of the type of
RPE cell (RPE, RPE-LC3B ) and the incubation condition (NA, OS, LGM2605, OS + LGM2605).
The ANOVA model included the two main effects from type of RPE cell and the incubation
condition and their interaction term. If there was no significant interaction (i.e., p > 0.05)
between RPE cell type and the incubation condition, two-way ANOVA was performed
without the interaction term, and the main effects for the type of RPE cell and the incubation
condition were determined. If there was significant interaction (p < 0.05) between RPE
cell type and the incubation condition, the main effect for the type of RPE cell and the
incubation condition was not determined. Instead, the pairwise comparisons across all the
combinations of RPE cell type and incubation condition were performed, and corrections
for multiple comparisons were made using Holm–Sidak method. When appropriate, the
unpaired t-test was also used to compare two means and a 2-tailed value of p < 0.05 was
considered statistically significant. * indicates p < 0.050, ** indicates, p < 0.020 and ***
indicates p < 0.001.
3. Results
3.1. Lipid Overload and Cytokine Release in RPE
We first sought to determine if we could recapitulate aspects of the Lc3b-/- RPE phenotype in vitro, with specific emphasis on lipid-mediated stress. We asked if delayed
phagosome degradation correlated with decreased ketogenic efficiency in RPE-LC3B cells.
In RPE-LC3B cells, β- hydroxybutyrate (β-HB) release decreased by 63% as compared to
RPE controls (Figure 1A).

by ELISA. 4-HNE peroxidation products were 3 fold higher in the RPE-LC3B cells than controls at day 7 of OS challenge (Figure 1D). By day 7, IL-1β release was 5- fold higher in
RPE-LC3B cells as compared to controls (Figure 1E). Membrane pores associated with the
release of IL-1 β may be due to the targeted cleavage of gasdermin [56]. Concomitant with
lipid deposits in RPE-LC3B was the cleavage of gasdermin (GSDMD), resulting in the forInt. J. Mol. Sci. 2021, 22, 5764
mation of an N-terminal 30kda fragment (GSDMD-N) shown to induce membrane pores
(Supplementary Figure S1) [55].
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In the next series of studies, we used a long-term, 7 day OS challenge model in which
we could assess the cumulative effects of OS uptake and ketogenic insufficiency over time.
On day 7 of the OS challenge, RPE-LC3B cells accumulated twice as much intracellular lipid
compared to control RPE (Figure 1B,C). The lipid deposits in RPE-LC3B appeared as larger
aggregates (Figure 1B, arrowhead and inset). When total fluorescence intensity of regions
of interest/cell (ROI/cell) was compared, a statistically significant increase in neutral
lipid-associated fluorescence was observed in RPE-LC3B challenged with outer segments
versus no addition of OS, as well as RPE + OS (Figure 1C). Enhanced lipid accumulation
in the oxidative stress environment of the RPE is predicted to result in enhanced lipid
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peroxidation. Lipid peroxidation levels were determined as 4-hydroxynonenal (4-HNE)adducts by ELISA. 4-HNE peroxidation products were 3 fold higher in the RPE-LC3B cells
than controls at day 7 of OS challenge (Figure 1D). By day 7, IL-1β release was 5- fold higher
in RPE-LC3B cells as compared to controls (Figure 1E). Membrane pores associated with
the release of IL-1 β may be due to the targeted cleavage of gasdermin [56]. Concomitant
with lipid deposits in RPE-LC3B was the cleavage of gasdermin (GSDMD), resulting in the
formation of an N-terminal 30 kda fragment (GSDMD-N) shown to induce membrane
pores (Supplementary Figure S1) [55].
3.2. LGM2605 Restores Oxidative Capacity and Decrease Cytokine Release in RPE
We then tested the hypothesis that LGM2605, the synthetic lignin, secoisolariciresinol
diglucoside (SDG) protects against oxidative stress and restores metabolic capacity to RPE
under lipid overload.
In this first series of experiments, we sought to determine if oxidative stress triggered
cytokine release was alleviated by LGM2605 using a well characterized oxidative stress
model [47,48]. RPE and RPE-LC3B cells treated with 200 µM H2 02 and 10 ng/mL TNF-α
and challenged with OS were pretreated with varying concentrations of LGM2605 (50–
200 µM). IL-1β release and cytotoxicity was analyzed 24 h later. IL-1β release decreased
by 65% with 50 µM LGM2605, with over 80% decrease when LGM2605 was increased
to 100 µM (Figure 2A). Coincident with the decrease in IL-1β was a decrease in stressinduced cytotoxicity, with a 60% decrease in cell leakiness to LDH in the presence of 100 µM
LGM2605 (Figure 2B). Neither TNF-α or H2 O2 alone triggered a significant effect under
these conditions; IL-1β release with 600 µM H2 O2 was 0.28 ± 0.08 ng/mL and with only
10 ng/mL TNF-α, IL-1β release was 0.34 ± 0.52 ng/mL, consistent with observations by
other groups [48]. LGM2605 at the concentrations used herein did not alter RPE barrier
integrity as measured by transepithelial resistance (TER). Routinely, TER values were between 156 and 164 (Ω/cm2 ) ± LGM2605 (50–100 µM) and are presented in Supplementary
Figure S2A. RPE cells remain viable as, the addition of LGM2605 did not alter RPE cell
morphology (Supplementary Figure S2B) and did not result in RPE cell death as detected
by TUNEL staining (Supplementary Figure S3). Routinely, over 98% of the cells treated
with LGM2605 (50 µM to 200 µM) were TUNEL negative. Moreover, LGM2605 addition
did not affect phagocytic function per se, as opsin levels 2 h after OS ingestion were equal
in the presence or absence of LGM2605 (Supplementary Figure S2C). Overall, LGM2605
decreased IL-1β secretion and protected the cells from oxidative stress-induced cytotoxicity.
Using this LGM2605 dose–response data, we turned our attention to understanding if
and how LGM2605 exerts an effect on our lipid overload stress model. Analysis of publicly
available microarray datasets for RPE (GSE62947) identified three genes of moderate
abundance in RPE, NQO1, GSTM1 and HO-1 (Figure 2C). The expression of these genes in
RPE and RPE-LC3B was analyzed in the presence of 100 µM LGM2605 in our 7 day lipid
overload stress model (Figure 2D,E). We detected a significant increase in NQO1 in RPE
(p = 0.0011) and RPE-LC3B (p = 0.0238) cells treated with OS plus LGM2605 (Figure 2D,E) as
compared to just OS (3.93 and 3.02 fold increase, respectively).
The RPE-LC3B cell, and to a lesser extent RPE, showed elevated levels of BODIPY
staining indicative of neutral lipid accumulation after daily challenge with OS over 7 days
(Figure 3B,D). When total fluorescence intensity of regions of interest/cell was compared, a
statistically significant decrease was observed when cells were pretreated with LGM2605
(100 µM, 30 min) prior to daily OS challenge in both RPE-LC3B (Figure 3C,D; lower panel)
and to a lesser extent in control RPE (Figure 3A,B; top panel).
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light in the range of 400–800 nm (Supplementary Figure S4B).
Based on the similarity between RPE and cardiomyocyte metabolic capacity, we assessed whether the beneficial effects of LGM2605 involved changes to mitochondrial function. RPE and RPE-LC3B cells treated with LGM2605 daily as described above showed an
increase in MitoTracker red staining, suggestive of enhanced mitochondrial abundance in
11 of 20
RPE-LC3B (Figure 4A,B). In accordance with these results, ketogenesis measured as β-HB
release reflecting mitochondrial function also increased in LGM2605 treated samples (Figure 4C). Given that LGM2605 restored ketogenic capacity, thereby reducing intracellular
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pairwise comparison using Holm–Sidak correction was used. For each independent experiment, we analyzed 5 fields of
cells, each containing at least 20 cells. * indicates p < 0.050. *** indicates p < 0.001.
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Table 1. IL-18 released into apical supernatant. RPE or RPE-LC3B cells were incubated once daily for
7 days. Each day of a 7-day long study, cells were either left untreated, pretreated with LGM2605
(100 µM) or challenged with OS, with or without (LGM2605 (100 µM) pretreatment. IL-18 released
into the apical media as measured by ELISA at day 2 and day 6 is indicated. Data shown is the mean
± SEM of three independent experiments, each in duplicate. * p < 0.050, and ** p < 0.020.
SAMPLE

IL-18 Released ng/mL
NA

+LGM2605

+OS

+OS and
LGM2605

RPE
Day 2
Day 6

0.11 ± 0.01
0.48 ± 0.04

0.73 ± 0.87
0.98 ± 0.12

1.47 ± 0.18 *
0.73 ± 0.84

2.21 ± 0.12 **
6.04 ± 0.44 **

RPE-LC3B
Day 2
Day 6

0.17 ± 0.02
0.11 ± 0.01

1.47 ± 0.12 *
0.36 ± 0.44

2.09 ± 0.33 **
1.10 ± 0.0.81 *

4.56 ± 0.89 **
0.73 ± 0.09 *

4. Discussion
In the present study, we focused on defining the relationship between defective phagosome clearance and loss of lipid homeostasis resulting in oxidative stress and cytokine
release by the RPE. We further evaluated the potential for LGM2605, a synthetic lignin with
potent antioxidant and mito-protective properties, to restore RPE lipid homeostasis and
ameliorate cytokine release. In vivo, delayed phagosome maturation, specifically the inability to utilize LC3B associated phagocytosis (LAP), resulted in diminished chromophore
recycling of a process necessary to support visual function [66] as well as loss of protective lipid mediators [48,67,68]. These consequences, as well as lipid accumulation and
peroxidation, all contributed to an overall proinflammatory environment resulting in microglial infiltration and loss of visual function [27]. Herein, we asked if lipid dysregulation
contributes to oxidative stress and inflammation using RPE-LC3B cells in which the major
trafficking partner in LAP, LC3B, has been knocked down. We assessed the consequences of
defective metabolic capacity in a cumulative OS uptake model [49], designed to recapitulate
the daily ingestion and degradation of lipid-rich OS carried out by the RPE in vivo. This
model has been used previously to assess the effectiveness of dopamine receptor agonists
on decreasing lipofuscin-like autofluorescent accumulation in RPE [49]. RPE-LC3B cells
show an ~65% decrease 5 in fatty acid oxidation (Figure 1A) and a concomitant increase in
intracellular lipid deposits (Figure 1B,C), which serve as substrates for oxidation reactions
resulting in the generation of 4-HNE. 4-HNE levels in RPE-LC3B were ~50% higher than
control RPE (Figure 1D). Oxidized lipids often directly contribute to tissue injury or react
with amines on proteins to form oxidation specific epitopes, which can induce an innate
immune response. Many oxidation-dependent changes, including, 4-HNE adducts have
been identified in AMD, further suggesting that oxidative stress is an important factor in
disease development. Over the 7 day OS uptake period, a steady time-dependent increase
in IL-1β release was seen in RPE-LC3B while little IL-1 β was released from control cells.
Interestingly, we observed a lipid accumulation-based increase in gasdermin processing
(Supplementary Figure S1). One of the key steps in caspase-1 and -4-mediated activation
of pyroptosis and the resulting release of proinflammatory cytokines is the cleavage of
GSDMD. Caspase-1 and caspase-4 cleavage removed the C-terminal fragment; this releases
and activates the N-terminal fragment, GSDMD-NT. This fragment is directly responsible
for pore formation in the plasma membrane, which in turn enhances cytokine release and
ultimately leads to cell death, as indicated by LDH release [67]. Gasdermin D levels have
been shown to be elevated in the RPE in human eyes with geographic atrophy [68]. In this
regard, studies looking at the relationship between gasdermin pore formation mediated
IL-1 β release and lipid homeostasis are underway. Collectively, these in vitro studies establish a model in which one can directly assess the impact of lipid metabolic dysregulation
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on inflammation. Moreover, they also provide a platform for us to assess the effectiveness
of LGM2650, a chemically synthesized secoisolariciresinol diglucoside (SDG).
SDG is a bioactive lignan component of flaxseed, is a non-toxic whole grain that
consists of high concentrations of omega-3 fatty acids and lignans. SDG is a potent antioxidant with anti-inflammatory and antifibrotic properties; the beneficial effects of SDG have
been documented in treating hypercholesterolemia, diabetes, postmenopausal symptoms,
cardiovascular disease, metabolic syndrome, bone disease, ischemia-reperfusion injury,
radiation-induced pneumonopathy and hyperoxia [69], and references therein. Chemically
synthesized SDG, LGM2605 is effective in several preclinical models of disease in which
oxidative stress and inflammation play a prominent role in pathogenesis [35,39–41]. Herein,
we show for the first time that LGM2605 protects the RPE against lipid overload and oxidative stress mediated cytokine release. In addition, we show LGM2605’s mitoprotective
properties in increasing mitochondrial abundance and mitochondrial metabolic capacity
with enhanced FAO and ketogenesis.
LGM2605 protected RPE cells from H2 O2 induced oxidative damage in a dosedependent manner (0–200 µM); when RPE was pretreated with LGM2605, prior to stress
induction, an 80% decrease in IL-1β release was observed with a corresponding increase in
cell viability (Figure 2A,B). These results are suggestive of the cytoprotective properties of
quercetin, a flavonoid compound that, among other properties, activates Nrf2 dependent
gene expression to protect RPE [47]. Similarly, LGM2605 stimulates Nrf2 dependent gene
expression, and herein, we show a statistically significant increase in Nqo-1 and HO-1,
when RPE cells were pretreated with LGM2605 prior to OS addition (Figure 2D). In cells,
similar increases in Nqo-1 and Ho-1 were observed upon LGM2605 treatment (Figure 2E),
albeit the RPE-LC3B baseline levels of these genes were higher in cells treated with OS only,
suggesting that in the absence of lipid degradation, there is a compensatory upregulation
of stress-response genes.
Although the exact mechanisms of action of SDG have not been fully explored, it has
known protective mechanisms including direct free radical scavenging activity, induction of
antioxidant response, anti-inflammatory properties, repression of inflammatory mediators
and mitochondrial homeostasis. The studies shown in Figure 3 also suggest antisteatosis.
After 7 days of daily OS challenge we observed a significant increase in neutral lipids
accumulated in both RPE and RPE-LC3B cells. When cells were pretreated with 100 µM
LGM2605 daily prior to OS addition, a substantial decrease in neutral lipid deposits was
observed; levels of intracellular neutral lipid fell to levels found in untreated cells. LGM2605
had no effect on phagosome maturation as detected by opsin degradation (Supplementary
Figure S2C).
The most straightforward hypothesis to consider in assessing the molecular mechanism by which LGM2605 decreased lipid accumulation was to ask whether this compound
was able to enhance lipid degradation, thereby decreasing available lipid for deposition.
Changes in metabolites of mitochondrial metabolism and glucose utilization are most commonly associated with the aging retina [70] metabolic dysfunction, including decreased
energy metabolism and impaired antioxidant defense, has been reported in retina and
RPE [71]. Age-related retinal disease is proposed to involve a cumulative metabolic decompensation in which the loss of mitochondrial oxidative function and mitochondrial stress
contribute to pathophysiology [1,2]. Therefore, to assess whether the beneficial effects of
LGM2605 involves changes in mitochondrial numbers, we stained 7 day OS challenged
RPE and RPE-LC3B cells with Mitotracker red at day 7. While there was a trend towards
increase Mitotracker staining, and hence mitochondrial numbers, in the RPE with LGM2605
treatment in the RPE-LC3B, a 2.5 fold statistically significant increase in mitochondrial
numbers was observed (Figure 4A,B). Consistent with enhanced mitochondrial function is
the stimulation of ketogenesis with twice as much βHB released in RPE-LC3B treated with
100 µM LGM2605. Similarly, enhanced ketogenic capacity ameliorates aspects of hepatic
steatosis [72]. Clues to the relationship between LGM2605 and mitochondrial function
come from the observations that Nrf-2 affects mitochondrial membrane potential, fatty
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